RGLS

Regulus Therapeutics Inc. News Headlines

$6.66
*  
0.17
2.49%
Get RGLS Alerts
*Delayed - data as of Oct. 1, 2014  -  Find a broker to begin trading RGLS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NASDAQ Biotechnology Top Performers (As Of Market Open September 11)
9/11/2014 8:27:38 AM - David Krein

5 Breakout Stocks Under $10 Set to Soar
9/4/2014 9:13:00 PM - TheStreet

Regulus Therapeutics To Present At Wedbush Conference; Webcast At 9:45 AM ET
8/13/2014 8:45:00 AM - RTT News

GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date
8/6/2014 12:02:00 AM - RTT News

Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential
8/4/2014 7:36:00 AM - Seeking Alpha

Alnylam And Benitec
7/25/2014 8:16:00 AM - Seeking Alpha

ACT Gets FDA Date, CGIX Opens Wallet, DPRX Once Again Takes OneStep Forward
7/21/2014 11:06:00 PM - RTT News

Sector Update: Health Care Stocks Mostly Lower; Regulus Therapeutics Wins Orphan Drug Designation for Prospective Kidney Disease Treatment
7/21/2014 2:34:13 PM - MT Newswires

Sector Update: Health Care
7/21/2014 2:06:38 PM - MT Newswires

Regulus Gets Orphan Drug Designation For RG-012 For Alport Syndrome
7/21/2014 12:48:00 PM - RTT News

Commit To Purchase Regulus Therapeutics At $10, Earn 27.1% Annualized Using Options
3/14/2014 11:45:45 AM - BNK Invest

Focus on Regulus' Pipeline - Analyst Blog
3/11/2014 7:00:01 PM - Zacks.com

Pipeline Progress at Regulus - Analyst Blog
2/20/2014 6:20:01 PM - Zacks.com

Regulus (RGLS) Jumps: Stock Rises 5.6% - Tale of the Tape
1/17/2014 10:46:01 AM - Zacks.com

Healthcare Stocks Climbing in Afternoon; Regulus Rises on Q3 Results, HPV Drug Prospects
11/14/2013 2:05:48 PM - MT Newswires

Sector Update: Healthcare
11/14/2013 2:03:11 PM - MT Newswires

Biopharma's Hot Stocks for this Week! - Earnings ESP
11/12/2013 1:05:20 PM - Zacks.com

Regulus Therapeutics Inc. Enters Oversold Territory - Tale of the Tape
10/23/2013 8:07:07 AM - Zacks.com

U.S. IPO Recap: Regado Slashes Valuation, 3 Deals Added To IPO Pipeline
8/26/2013 2:56:00 PM - Seeking Alpha

US IPO Recap: Regado slashes valuation, three deals added to IPO pipeline
8/26/2013 9:03:53 AM - Renaissance Capital

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha

Regulus Therapeutics: Strong Balance Sheet As It Moves Into Clinical Development
5/6/2013 2:40:00 PM - Seeking Alpha

March Shows Solid IPO Momentum Into April
4/9/2013 7:46:00 AM - Seeking Alpha

Sangamo Bioscience: The Impending Failure In HIV
3/13/2013 6:26:00 AM - Seeking Alpha

Alnylam: Further Evidence That The Stock Is Overvalued
11/19/2012 8:00:00 AM - Seeking Alpha